Two Successfully Treated Cases of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome): a Review of Literature and Case Report

Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), also known as druginduced hypersensitivity syndrome (DIHS), is a rare, severe, potentially life-threatening disorder that might affect internal organs.DRESS differs from other drug eruptions by late onset and the possible persistence or worsening even after drug discontinuation [1].Clinical presentation of DRESS encompasses a wide spectrum of symptoms, including cutaneous eruptions such as a maculopapular rash, fever, lymphadenopathy, hematological abnormalities (e.g.eosinophilia and atypical lymphocytes), facial edema, and multi-organ involvement affecting the liver, kidneys, lungs, pancreas, heart, and other organs.Compared to other cutaneous adverse drug reactions, DRESS has a delayed onset, with initial symptoms typically appearing 2 to 8 weeks after treatment initiation, although this timeframe may vary depending on the specific drug administered.Having been reexposed to the drug, the patient develops symptoms more rapidly.The most common causes of DRESS are aromatic antiepileptic agents, allopurinol, AbstrActIntroduction: Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) is an uncommon yet potentially fatal hypersensitivity reaction triggered by specific medications.A typical clinical presentation consists of maculopapular skin lesions, eosinophilia, fever and internal organ involvement.Case report: This report highlights 2 cases of the DRESS syndrome caused by antiepileptic drug -lamotrigine and antibiotic -azithromycin.The first case involves an 18-year-old who developed widespread maculopapular rash, fever, lymphadenopathy, and elevated liver enzymes 3 weeks after initiating lamotrigine.The second case describes a 53-year-old female with severe rash covering 90% of her body, eosinophilia, and liver enzyme abnormalities shortly after azithromycin administration.Immediate discontinuation of the drug, combined with topical and systemic corticosteroids treatment led to the desired outcomes in both cases.Conclusions: These cases underscore the critical importance of early diagnosis and management of DRESS, particularly when prescribing commonly used medications such as antiepileptic drugs and antibiotics.

Authors

Publication Details

Journal
Dermatology Review
Published
2025-01-01
DOI
https://doi.org/10.5114/dr.2025.154375
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Two Successfully Treated Cases of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome): a Review of Literature and Case Report

Karolina Rutkowska, Małgorzata Sankowska, Ewelina Biało-Wójcicka
Dermatology Review
Drug-Induced Adverse Reactions
article

Two Successfully Treated Cases of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome): a Review of Literature and Case Report

Karolina Rutkowska, Małgorzata Sankowska, Ewelina Biało-Wójcicka
article en

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), also known as druginduced hypersensitivity syndrome (DIHS), is a rare, severe, potentially life-threatening disorder that might affect internal organs.DRESS differs from other drug eruptions by late onset and the possible persistence or worsening even after drug discontinuation [1].Clinical presentation of DRESS encompasses a wide spectrum of symptoms, including cutaneous eruptions such as a maculopapular rash, fever, lymphadenopathy, hematological abnormalities (e.g.eosinophilia and atypical lymphocytes), facial edema, and multi-organ involvement affecting the liver, kidneys, lungs, pancreas, heart, and other organs.Compared to other cutaneous adverse drug reactions, DRESS has a delayed onset, with initial symptoms typically appearing 2 to 8 weeks after treatment initiation, although this timeframe may vary depending on the specific drug administered.Having been reexposed to the drug, the patient develops symptoms more rapidly.The most common causes of DRESS are aromatic antiepileptic agents, allopurinol, AbstrActIntroduction: Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) is an uncommon yet potentially fatal hypersensitivity reaction triggered by specific medications.A typical clinical presentation consists of maculopapular skin lesions, eosinophilia, fever and internal organ involvement.Case report: This report highlights 2 cases of the DRESS syndrome caused by antiepileptic drug -lamotrigine and antibiotic -azithromycin.The first case involves an 18-year-old who developed widespread maculopapular rash, fever, lymphadenopathy, and elevated liver enzymes 3 weeks after initiating lamotrigine.The second case describes a 53-year-old female with severe rash covering 90% of her body, eosinophilia, and liver enzyme abnormalities shortly after azithromycin administration.Immediate discontinuation of the drug, combined with topical and systemic corticosteroids treatment led to the desired outcomes in both cases.Conclusions: These cases underscore the critical importance of early diagnosis and management of DRESS, particularly when prescribing commonly used medications such as antiepileptic drugs and antibiotics.

Dermatology ReviewVol. 112(3)
Openalex Percentile: Top 69%
Drug-Induced Adverse Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.